Related Experiment Video
Updated: Aug 29, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B
Song-Mei Lou1, You-Ming Li, Kai-Ming Wang
1Department of Gastroenterology, Hangzhou First People's Hospital, Hangzhou 310006, Zhejiang Province, China. lousm_72@hotmail.com
Insights
Platelet-derived growth factor-BB (PDGF-BB) expression correlates with liver inflammation and fibrosis in chronic hepatitis B. This suggests PDGF-BB may contribute to the development and progression of liver fibrosis.
Area of Science:
- Hepatology
- Oncology
- Immunology
Background:
- Chronic hepatitis B is a significant cause of liver disease worldwide.
- Liver fibrosis is a key pathological process in chronic hepatitis B, potentially leading to cirrhosis and hepatocellular carcinoma.
- Platelet-derived growth factor-BB (PDGF-BB) is a potent mitogen and signaling molecule implicated in tissue repair and fibrosis.
Purpose of the Study:
- To investigate the association between PDGF-BB expression and fibrogenesis in patients with chronic hepatitis B.
- To determine if PDGF-BB levels correlate with histological findings of inflammation and fibrosis.
- To explore the relationship between tissue PDGF-BB expression and specific biomarkers of fibrosis in circulation.
Main Methods:
- Hepatic tissue samples from 43 chronic hepatitis B patients were analyzed.
- Histological assessment included HE and picric acid-sirius red staining for inflammation and fibrosis.
- Immunohistochemistry quantified PDGF-BB expression; serum levels of hyaluronic acid, pro-collagen III, collagen IV, and laminin were measured by RIA.
Main Results:
- PDGF-BB expression showed a significant positive correlation with inflammatory activity (tau=0.58) and fibrosis stage (tau=0.55) in liver tissue.
- Tissue PDGF-BB levels were also positively correlated with serum concentrations of hyaluronic acid (r=0.52), pro-collagen III (r=0.32), collagen IV (r=0.40), and laminin (r=0.33).
- These findings indicate a strong link between PDGF-BB and fibrotic processes in chronic hepatitis B.
Conclusions:
- PDGF-BB expression is closely associated with liver inflammation and fibrosis in chronic hepatitis B.
- The results suggest that PDGF-BB plays a role in the pathogenesis and advancement of liver fibrosis.
- Targeting PDGF-BB may represent a potential therapeutic strategy for managing liver fibrosis in chronic hepatitis B.
Aim:
To study the relationship between expression of platelet-derived growth factor-BB (PDGF-BB) and fibrogenesis in chronic hepatitis B.
Methods:
Hepatic tissues from 43 patients with chronic hepatitis B were embedded in paraffin. The sections were stained with HE and picric acid-sirius red to determine inflammatory activity and fibrosis stages. PDGF-BB expression was detected by immunohistochemistry and assessed semiquantatively. Levels of serum hyaluronic acid (HA), pro-collagen III (PCIII), collagen IV (IV-C) and laminin (LN) were examined by radioimmunoassay (RIA).
Results:
The expression level of PDGF-BB was found to be positively correlated with inflammatory activity, fibrosis stage and grade of histological findings (tau=0.58, 0.55, 0.55, P<0.01). The positive correlation was also observed between tissue level of PDGF-BB expression and contents of HA, PCIII, IV-C and LN in the circulation (r=0.52, 0.32, 0.40, 0.33, P<0.05).
Conclusion:
PDGF-BB may play some role in the development and progression of liver fibrosis.
Related Concept Videos
Hepatitis
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction

